MedEasy
Bangladesh
- Dhaka, Dhaka
- 11/09/2023
- Seed
- $750,000
MedEasy is the no. 1 online pharmacy & healthcare app in Bangladesh. MedEasy app enables you to connect with licensed doctors from 23 specialties and, receive consultations through video calling from anywhere. We also provide doorstep diagnostic services.
- Industry Wellness and Fitness Services
- Website https://medeasy.health/
- LinkedIn https://www.linkedin.com/company/medeasy-healthcare-limited/about/
Related People
Arefin ZamanCo Founder
Bangladesh -
ND
I have 5 years of experience in Machine Learning & Natural Language Processing which is demonstrated by 4 peer-reviewed research papers. Google Scholar profile: (https://scholar.google.com/citations?user=Qkw-8fYAAAAJ&hl=en). I was a senior machine learning engineer at Socian where we built the first-ever commercial Bangla speech recognition system made in Bangladesh. We also built chatbot and NLU systems for clients like Grameenphone (Leading telco in Bangladesh) & the govt. of Bangladesh.
Co-founded one of the fastest-growing digital health startups in Bangladesh - MedEasy. MedEasy is a mobile app that streamlines the whole patient journey from consultation to medicine delivery to accessing hospital records & services for 30 million chronic patients in Bangladesh. We have grown 5x in revenue in 2022 and our user base is 100,000+ strong now.
Contact me: arefin@medeasy.health
Download MedEasy app: https://cutt.ly/fQdsnuL
Visit our website: medeasy.health
Parhelia Biosciences | Undisclosed Amount | (Oct 18, 2023)
Cloover | $7,388,000 | (Oct 18, 2023)
Hallmark Health Care Solutions | Undisclosed Amount | (Oct 18, 2023)
Prove | $40,000,000 | (Oct 18, 2023)
Reality Defender | $15,000,000 | (Oct 18, 2023)
Yardstik | $12,000,000 | (Oct 18, 2023)
Nucleus RadioPharma | $56,000,000 | (Oct 18, 2023)
Society Brands | $25,000,000 | (Oct 18, 2023)
Nova Credit | $45,000,000 | (Oct 18, 2023)
Anonybit | $3,000,000 | (Oct 18, 2023)
Zelus Analytics | Undisclosed Amount | (Oct 18, 2023)
Scorability | $11,000,000 | (Oct 18, 2023)